Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Subphenotype-dependent disease markers for diagnosis and personalized treatment of autism spectrum disorders.

Disease markers - 1 Jan 2012

Hu Valerie W

Abstract excerpt

Autism spectrum disorders (ASD) are a collection of neurodevelopmental disorders that are currently diagnosed solely on the basis of abnormal reciprocal language and social development as well as stereotyped behaviors. Without genetic or molecular markers for screening, individuals with ASD are typically not diagnosed before the age of 2, with milder cases diagnosed much later. Because early diagnosis is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child Development Disorders, Pervasive
Share to Circadian Rhythm Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Genetic Markers

Share to Phenotype

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 22960334
DOI: 10.3233/DMA-2012-0916
PMCID: PMC3810690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Subphenotype-dependent disease markers for diagnosis and personalized treatment of autism spectrum disorders.PMID 22960334Read ↗

Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD)Semantic proximity Read ↗

Current progress and challenges in the search for autism biomarkers.Semantic proximity Read ↗

Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders.Semantic proximity Read ↗

Diagnosis and management of autism spectrum disorder in the era of genomics: rare disorders can pave the way for targeted treatments.Semantic proximity Read ↗

An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment OptionsSemantic proximity Read ↗

Disentangling the heterogeneity of autism spectrum disorder through genetic findings.Semantic proximity Read ↗

Clinical Profiles in Autism Spectrum Disorder: Enhancing Diagnosis, Treatment, and Overall Health OutcomesSemantic proximity Read ↗

Genetics of autism spectrum disorder.Semantic proximity Read ↗

Genomic strategies to untangle the etiology of autism: A primer.Semantic proximity Read ↗

Risk factors, diagnosis, prognosis and treatment of autism.Semantic proximity Read ↗

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.Semantic proximity Read ↗

Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum DisorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.